Ana Navas-Acien Selected Research

Arsenic

1/2022	Toxic Metals and Subclinical Atherosclerosis in Carotid, Femoral, and Coronary Vascular Territories: The Aragon Workers Health Study.
1/2022	The association of arsenic exposure and arsenic metabolism with all-cause, cardiovascular and cancer mortality in the Strong Heart Study.
1/2022	Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease.
1/2021	Urinary arsenic and heart disease mortality in NHANES 2003-2014.
1/2021	Arsenic Exposure, Arsenic Metabolism, and Glycemia: Results from a Clinical Population in New York City.
1/2021	Arsenic, blood pressure, and hypertension in the Strong Heart Family Study.
1/2021	Rare, Protein-Altering Variants in AS3MT and Arsenic Metabolism Efficiency: A Multi-Population Association Study.
1/2021	Toenails as a biomarker of exposure to arsenic: A review.
12/2020	Association between rice consumption and risk of cancer incidence in the California Teachers Study.
12/2020	Urinary Arsenic and Cadmium Associations with Findings from Cranial MRI in American Indians: Data from the Strong Heart Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Navas-Acien Research Topics

Disease

49	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 12/2005
23	Atherosclerosis 01/2022 - 06/2004
18	Neoplasms (Cancer) 01/2022 - 02/2008
15	Hypertension (High Blood Pressure) 01/2021 - 01/2008
13	Peripheral Arterial Disease 01/2022 - 06/2004
12	Chronic Renal Insufficiency 12/2021 - 11/2009
11	Coronary Disease (Coronary Heart Disease) 01/2021 - 12/2005
8	Inflammation (Inflammations) 01/2020 - 11/2014
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2006
6	Myocardial Infarction 10/2022 - 11/2015
5	Insulin Resistance 01/2020 - 11/2012
5	Kidney Diseases (Kidney Disease) 02/2019 - 03/2013
5	Stroke (Strokes) 12/2017 - 12/2005
5	Lung Neoplasms (Lung Cancer) 01/2017 - 07/2013
4	Lung Diseases (Lung Disease) 01/2022 - 02/2009
4	Chronic Disease (Chronic Diseases) 01/2021 - 02/2015
4	Heart Diseases (Heart Disease) 01/2021 - 07/2012
4	Albuminuria 01/2017 - 11/2009
4	Rhinosinusitis 02/2014 - 11/2009
3	Obesity 01/2021 - 12/2012
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 04/2012
3	Rhinitis 01/2017 - 01/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 12/2009 - 01/2008
2	Prediabetic State (Prediabetes) 01/2021 - 12/2017
2	Premature Birth (Birth, Premature) 01/2019 - 09/2014
2	Asthma (Bronchial Asthma) 01/2019 - 03/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2018 - 01/2018
2	Infections 01/2017 - 10/2015
2	Diabetes Mellitus 11/2015 - 04/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2015 - 02/2015
2	Frailty 02/2015 - 01/2015
1	Non-alcoholic Fatty Liver Disease 10/2022
1	Fatty Liver 10/2022
1	Fibrosis (Cirrhosis) 10/2022
1	Nephrolithiasis 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021
1	Parkinson Disease (Parkinson's Disease) 10/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2021
1	Mobility Limitation (Difficulty Walking) 05/2021
1	Hyperemia 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021

Drug/Important Bio-Agent (IBA)

58	ArsenicIBA 01/2022 - 12/2005
28	CadmiumIBA 10/2022 - 06/2004
16	MetalsIBA 10/2022 - 05/2013
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2005
13	SmokeIBA 01/2018 - 02/2009
9	SeleniumIBA 11/2022 - 10/2006
9	CreatinineIBA 01/2022 - 11/2009
9	Drinking WaterIBA 10/2021 - 07/2010
8	CotinineIBA 01/2018 - 05/2013
8	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2018 - 04/2011
4	CalciumIBA 01/2022 - 08/2016
4	AntimonyIBA 01/2022 - 03/2016
4	Particulate MatterIBA 10/2021 - 03/2015
4	arsenobetaineIBA 01/2021 - 08/2008
4	C-Reactive ProteinIBA 01/2020 - 04/2015
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2008
4	AllergensIBA 01/2017 - 01/2015
4	AntioxidantsIBA 11/2014 - 01/2008
3	Unithiol (DMPS)IBA 01/2022 - 01/2020
3	AlbuminsIBA 12/2021 - 03/2013
3	Biological ProductsIBA 01/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
3	TungstenIBA 10/2018 - 03/2016
3	AntigensIBA 01/2017 - 01/2015
3	Immunoglobulin E (IgE)IBA 01/2017 - 01/2015
2	MercuryIBA 10/2022 - 09/2012
2	Edetic Acid (EDTA)FDA Link 01/2022 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
2	LipidsIBA 01/2021 - 11/2013
2	HDL CholesterolIBA 01/2021 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 08/2013
2	Cacodylic Acid (Cacodylate)IBA 01/2021 - 08/2008
2	Fibrinogen (Factor I)FDA Link 01/2020 - 04/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2015
2	CopperIBA 01/2020 - 12/2019
2	LDL CholesterolIBA 01/2020 - 02/2015
2	ZincIBA 01/2020 - 12/2019
2	ChromiumIBA 12/2019 - 12/2016
2	VanadiumIBA 12/2019 - 12/2016
2	BariumIBA 12/2019 - 12/2016
2	MolybdenumIBA 12/2019 - 10/2018
2	Air Pollutants (Pollutants, Air)IBA 12/2018 - 04/2017
2	UraniumIBA 12/2016 - 03/2016
2	Uric Acid (Urate)IBA 03/2015 - 04/2012
2	Menthol FDA Link 07/2013 - 01/2013
1	MineralsIBA 10/2022
1	ManganeseIBA 10/2022
1	SolutionsIBA 10/2022
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2022
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 10/2022
1	TitaniumIBA 01/2022
1	Chelating AgentsIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Divalent CationsIBA 01/2022
1	CatecholaminesIBA 01/2021

Therapy/Procedure

4	Chelation Therapy (Therapy, Chelation) 01/2022 - 11/2015
2	Therapeutics 01/2019 - 01/2008
1	Activities of Daily Living (ADL) 05/2021